Survey: Retailers plan to spend more on e-commerce this year
DURHAM, N.C. — More than two-fifths of retailers plan to increase spending on online marketing this year, and nearly half have invested in new mobile apps, according to a new survey.
The survey, titled "Loading the Sleigh: Marketers’ Plans & Expectations for the Holiday Season," conducted by Retail Systems Research on behalf of Bronto Software over the summer, included 179 respondents, mostly with annual sales of between $51 million and $999 million. Bronto makes software for retailers and other commerce-focused companies.
Sixty-eight percent of respondents said they expect sales to increase from last year, with more than a quarter saying sales will increase by more than 50%. At the same time, 21% said they would "significantly" increase online marketing budgets compared with 2011, while 22% plan to slightly increase them.
"Retailers clearly recognize the need to market online during the holidays, when they are under the most pressure to capture consumer wallet share," Bronto CEO Joe Colopy said. "This study shows that these marketers have made important investments over the year, so they are poised to accomplish their goals. And while mail is a more established channel and has inherent technologic advantages for communicating with consumers, marketers are getting ready to use mobile and social to break out of the pack."
Retailers have made several investments in e-commerce marketing. Forty-nine percent have invested in mobile applications, while 46% have invested in new e-commerce platforms. Fifty percent have found new email service providers, while 43% have invested in mobile website optimization.
But as Colopy suggested, most are budgeting for email marketing, with 87% saying they would spend on that this year and more than half saying they expect the overall volume of emails they send to increase over 2011.
As many as one-third plan to wait until after Black Friday weekend to begin their first promotions, and all are planning to offer free shipping offers.
Chemotherapy drug shows “significant” improvement in melanoma patients in late-stage trial
BOUDRY, Switzerland — A Swiss subsidiary of drug maker Celgene Corp. said its chemotherapy drug produced "significant" improvement in progression-free survival in patients with a deadly skin cancer that had spread elsewhere in the body.
Celgene International Sarl announced the publication of abstracts from its phase-3 trial of Abraxane in melanoma patients in the journal of the Society for Melanoma Research, with plans to present the findings at an upcoming meeting of the organization. Abraxane is a formulation of the drug paclitaxel bound in the human protein albumin and free of solvents already approved for treating several other cancers.
"Metastatic melanoma presents significant treatment challenges due in part to limited therapies, low survival rates at diagnosis and no advances in chemotherapy in 37 years," University of Arizona professor of medicine and lead study investigator Evan Hersh said. "Despite advances with targeted treatment and immunotherapies, there is still a need for new agents, including chemotherapy treatments, for patients with metastatic melanoma."
The trial included patients with metastatic melanoma who had not received chemotherapy before, comparing them to patients receiving dacarbazine chemotherapy. Results of the trial indicate that Abraxane was more effective, Celgene said.
Walgreens re-ups alliance with American Diabetes Association through 2013
ALEXANDRIA, Va. — The American Diabetes Association on Wednesday announced that Walgreens has reaffirmed its commitment as a National Strategic Partner and will continue to help the program Stop Diabetes by supporting the association’s Type 2 diabetes prevention initiative for consumers called CheckUp America.
"Education is crucial for the prevention of type 2 diabetes," stated Larry Hausner, ADA CEO. "Since the alliance was formed in 2011, Walgreens has raised more than $1.6 million for the Association and has helped us reach out to communities with critical information through our educational initiatives."
Walgreens will support the expanded distribution of patient education materials and the development of a transit advertising campaign in select markets to encourage consumers to find out their risk for diabetes, ADA reported.
The relationship kicks off this November during American Diabetes Month, as Walgreens will be conducting a pin pad donation campaign when a debit or credit card is used for payment. Walgreens will also be continuing its commitment to education by participating in select American Diabetes Association Expos — free events for the public featuring education about healthy eating, active living and changing the future of diabetes. In addition to its commitment in educating the public, Walgreens will again be a national sponsor of Step Out: Walk to Stop Diabetes, and will encourage its employees to get out and walk as part of the Walgreens nationwide team for Step Out.